Certara, Inc.
About Certara, Inc.
Certara Inc accelerates medicines to patients using biosimulation software and technology to transform traditional drug discovery and development. It provides modeling and simulation, regulatory science, and assessment software and services to help clients reduce clinical trials, accelerate regulatory approval, and increase patient access to medicines. The company has its business presence in the Americas, which is also its key revenue-generating market, EMEA, and the Asia Pacific region.
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Revenue FY2025
- $418.8M
- Net income
- -$1.6M
- Total assets
- $1.6B
- Market cap
- $835.4M
- Operating margin
- 5.0%
- Net margin
- -0.4%
Source: SEC EDGAR · updated Jun 7, 2026
Revenue & profit trend
Financial statements
Income statement
- Revenue
- $418.8M
- Operating expenses
- $236.7M
- Operating income
- $21.0M
- Income tax
- $9.2M
- Net income
- -$1.6M
- EPS (basic)
- $-0.01
- EPS (diluted)
- $-0.01
Balance sheet
- Total assets
- $1.6B
- Current assets
- $315.1M
- Total liabilities
- $493.8M
- Current liabilities
- $153.4M
- Shareholders’ equity
- $1.1B
Cash flow
- Operating cash flow
- $96.3M
- Investing cash flow
- -$26.6M
- Financing cash flow
- -$64.0M
- Net cash flow
- $10.2M
Statements via Polygon.io (SEC filings)
15-minute delayed · data by Polygon.io
Past year
52-week range
- Market cap
- $835.4M
- EPS (diluted)
- $-0.01
- Shares outstanding
- 160.0M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Dec 11, 2020
Market data by Polygon.io · prices are 15-minute delayed
At a glance
- Reported a net loss of $1.6M in FY2025.
- Revenue grew 46% from FY2021 to FY2025.
- Trading 62% below its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review Certara, Inc..
Write a review
News about Certara, Inc.
News & sentiment via Polygon.io
